Clinical Trials

51 studies in Neurology - Enterprise

  1. Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
    1. Florida
  2. Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
    1. Minnesota
  3. Neurotransmitter Measurements Using Wireless Instantaneous Neurotransmitter Concentration System (WINCS) During Deep Brain Stimulation Neurosurgery.
    1. Minnesota
  4. A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old With Intensive Induction Chemotherapy With Methotrexate Followed by Consolidation With Stem Cell Rescue Versus the Same Therapy Without Methotrexate
    1. Minnesota
  5. Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
    1. Florida
  6. A Multi-Center, Randomized, Placebo Controlled, Double-Blinded, Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury
    1. Minnesota
  7. Endovascular Arterial Reperfusion vs. Intravenous ThromboLYsis for Acute Ischemic Stroke (EARLY): A Randomized Pilot Study of Ultra-early (<2 Hours) and Early (2-4.5 Hours) Reperfusion Therapy
    1. Florida
  8. Multicenter Randomized Controlled Trial of Epidural Steroid Injections for Spinal Stenosis in Persons 65 and Older
    1. Minnesota
  9. Treatment Trial of Droxidopa and Pyridostigmine to Improve Orthostatic Hypotension Without Aggravating Supine Hypertension
    1. Minnesota
  10. Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
    1. Minnesota
  1. Prev
  2. 3
  3. 4
  4. 5
  5. 6
  6. Next

Clinical Trials

51 studies in Neurology - Enterprise

  1. Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
    1. Florida
  2. Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
    1. Minnesota
  3. Neurotransmitter Measurements Using Wireless Instantaneous Neurotransmitter Concentration System (WINCS) During Deep Brain Stimulation Neurosurgery.
    1. Minnesota
  4. A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old With Intensive Induction Chemotherapy With Methotrexate Followed by Consolidation With Stem Cell Rescue Versus the Same Therapy Without Methotrexate
    1. Minnesota
  5. Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
    1. Florida
  6. A Multi-Center, Randomized, Placebo Controlled, Double-Blinded, Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury
    1. Minnesota
  7. Endovascular Arterial Reperfusion vs. Intravenous ThromboLYsis for Acute Ischemic Stroke (EARLY): A Randomized Pilot Study of Ultra-early (<2 Hours) and Early (2-4.5 Hours) Reperfusion Therapy
    1. Florida
  8. Multicenter Randomized Controlled Trial of Epidural Steroid Injections for Spinal Stenosis in Persons 65 and Older
    1. Minnesota
  9. Treatment Trial of Droxidopa and Pyridostigmine to Improve Orthostatic Hypotension Without Aggravating Supine Hypertension
    1. Minnesota
  10. Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
    1. Minnesota
  1. Prev
  2. 3
  3. 4
  4. 5
  5. 6
  6. Next
.

Mayo Clinic Footer